Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets

Saved in:
Bibliographic Details
Published in:Thrombosis research 2010-09, Vol.126 (3), p.e235-e237
Main Authors: Le Cam-Duchez, Véronique, Frétigny, Mathilde, Cailleux, Nicole, Gandelin, Catherine, Lévesque, Hervé, Borg, Jeanne-Yvonne
Format: Article
Language:English
Subjects:
Administration, Oral
Adult
Aged
Algorithms
Aryl Hydrocarbon Hydroxylases - genetics
Blood Coagulation - drug effects
Blood Coagulation - genetics
CYP2C9
Cytochrome P-450 CYP2C9
Drug Dosage Calculations
Drug Monitoring
Female
Fibrinolytic Agents - administration & dosage
France
Genotype
Hematology, Oncology and Palliative Medicine
Humans
International Normalized Ratio
Male
Middle Aged
Mixed Function Oxygenases - genetics
Oral anticoagulant treatment
Pharmacogenetic
Pharmacogenetics
Phenotype
Polymorphism, Genetic
Thrombosis - blood
Thrombosis - prevention & control
Vitamin K Epoxide Reductases
VKORC1
Warfarin
Warfarin - administration & dosage
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0049-3848
1879-2472
DOI:10.1016/j.thromres.2010.05.003